市場調查報告書 - 222300

敗血性休克:全球臨床實驗檢討

Septic Shock Global Clinical Trials Review, H2, 2012

出版商 GlobalData
出版日期 2012年08月15日 內容資訊 英文 Pages: 87
價格
敗血性休克:全球臨床實驗檢討 Septic Shock Global Clinical Trials Review, H2, 2012
出版日期: 2012年08月15日 內容資訊: 英文 Pages: 87
簡介

本報告提供全球各國敗血性休克的臨床實驗的相關調查,彙整各地區、進展狀況、各階段、各募集情況的實驗量,代表性贊助商,正在開發的治療藥物的資訊,各企業機關的進行狀況等資訊,為您概述為以下內容。

目錄

目錄

  • 表格一覽
  • 圖表一覽
  • 簡介
  • 敗血性休克
  • 報告指南
  • 臨床實驗 各地區
  • 臨床實驗 各國
  • 對臨床實驗有所貢獻的前五國 - 亞太地區
  • 對臨床實驗有所貢獻的前五國 - 歐洲
  • 對臨床實驗有所貢獻的前幾名國家 - 北美
  • 對臨床實驗有所貢獻的前幾名國家 - 中東及非洲
  • 對臨床實驗有所貢獻的前幾名國家 - 中南美
  • 臨床實驗 - 金磚四國 各國
  • 臨床實驗 - G7 各國
  • 臨床實驗 - G7 各國 各臨床實驗狀態
  • 臨床實驗 - E7 各國
  • 臨床實驗 - E7 各國 各臨床實驗狀態
  • 臨床實驗 各階段
  • 進行中的臨床實驗 各階段
  • 臨床實驗 各臨床實驗狀態
  • 未完成的臨床實驗; 敗血性休克
  • 每段時期的實驗人數
  • 有力的贊助商
  • 前幾名參與企業 - 敗血性休克 治療藥物的臨床實驗
  • 潛力治療藥物比較
  • 臨床實驗簡介
  • 臨床實驗概要; 前幾名企業
  • AstraZeneca PLC
  • 臨床實驗概要; AstraZeneca PLC
  • Hospital Distrital Dr Fernandes Tavora
  • 臨床實驗概要; Hospital Distrital Dr Fernandes Tavora
  • Fraser Health Corporate Office
  • 臨床實驗概要; Fraser Health Corporate Office
  • Athlomics Pty Ltd
  • 臨床實驗概要; Athlomics Pty Ltd
  • Laboratoire francais de Fractionnement et de Biotechnologies
  • 臨床實驗概要; Laboratoire francais de Fractionnement et de Biotechnologies
  • Aventis Behring GmbH
  • 臨床實驗概要; Aventis Behring GmbH
  • Ferring Pharmaceuticals, Inc.
  • 臨床實驗概要; Ferring Pharmaceuticals, Inc.
  • Spectral Diagnostics Inc.
  • 臨床實驗概要; Spectral Diagnostics Inc.
  • Atox Bio Inc.
  • 臨床實驗概要; Atox Bio Inc.
  • Eisai公司
  • 臨床實驗概要; Eisai公司
  • Green Cross Corporation
  • 臨床實驗概要; Green Cross Corporation
  • Eli Lilly and Company
  • 臨床實驗概要; Eli Lilly and Company
  • 臨床實驗概要; 最高級大學 / 研究機關 / 醫院
  • Sapienza University of Rome
  • 臨床實驗概要; Sapienza University of Rome
  • Beth Israel Deaconess Medical Center
  • 臨床實驗概要; Beth Israel Deaconess Medical Center
  • Charite University
  • 臨床實驗概要; Charite University
  • The University of Texas Health Science Center at Houston
  • 臨床實驗概要; The University of Texas Health Science Center at Houston
  • The Medical Center Leeuwarden
  • 臨床實驗概要; The Medical Center Leeuwarden
  • Herlev Hospital
  • 臨床實驗概要; Herlev Hospital
  • Carolinas Healthcare System
  • 臨床實驗概要; Carolinas Healthcare System
  • Mahidol University
  • 臨床實驗概要; Mahidol University
  • Hospital Clinic de Barcelona
  • 臨床實驗概要; Hospital Clinic de Barcelona
  • University of Sao Paulo
  • 臨床實驗概要; University of Sao Paulo
  • London Health Sciences Centre
  • 臨床實驗概要; 倫敦 Health Sciences Centre
  • Research & Diagnostic Antibodies
  • 臨床實驗概要; Research & Diagnostic Antibodies
  • Southeast University
  • 臨床實驗概要; Southeast University
  • University Hospital, Grenoble
  • 臨床實驗概要; University Hospital, Grenoble
  • Washington University School of Medicine
  • 臨床實驗概要; Washington University School of Medicine
  • Assistance Publique - Hopitaux de Paris
  • 臨床實驗概要; Assistance Publique - Hopitaux de Paris
  • Austin Health
  • 臨床實驗概要; Austin Health
  • University of Copenhagen
  • 臨床實驗概要; University of Copenhagen
  • National Center for Genome Resources
  • 臨床實驗概要; National Center for Genome Resources
  • Rush University Medical Center
  • 臨床實驗概要; Rush University Medical Center
  • Five 主要 臨床簡介

附錄

  • 簡稱
  • 定義
  • 調查方法
  • 二級研究
  • 關於GlobalData
  • 諮詢方式
  • 免責聲明
  • 資訊來源

表格一覽

  • 敗血性休克 全球治療藥物市場, 臨床實驗 各地區
  • 敗血性休克 全球治療藥物市場, 臨床實驗 各國排名
  • 敗血性休克 全球治療藥物市場, 進行中的臨床實驗 各國排名
  • 敗血性休克 治療藥物的臨床實驗, 亞太地區, 前五國
  • 敗血性休克 治療藥物的臨床實驗, 歐洲, 前五國
  • 敗血性休克 治療藥物的臨床實驗, 北美, 前幾名國家
  • 敗血性休克 治療藥物的臨床實驗, 中東及非洲, 前幾名國家
  • 敗血性休克 治療藥物的臨床實驗, 中南美, 前幾名國家
  • 敗血性休克 治療藥物的臨床實驗, 金磚四國 各國
  • 敗血性休克 治療藥物的臨床實驗, G7 各國
  • 敗血性休克 治療藥物市場, G7 各國, 臨床實驗 各臨床實驗狀態
  • 敗血性休克 治療藥物的臨床實驗, E7 各國
  • 敗血性休克 治療藥物市場, E7 各國, 臨床實驗 各臨床實驗狀態
  • 敗血性休克 全球治療藥物市場, 臨床實驗 各階段
  • 敗血性休克 全球治療藥物市場, 進行中的臨床實驗 各階段
  • 敗血性休克 全球治療藥物市場, 臨床實驗 各臨床實驗狀態
  • 敗血性休克 全球治療藥物市場, 一時中止的臨床實驗
  • 敗血性休克 全球治療藥物市場, 終止的臨床實驗
  • 敗血性休克 全球治療藥物臨床實驗, 平均登錄對象人數趨勢
  • 敗血性休克 全球治療藥物臨床實驗, 主要的贊助商
  • 敗血性休克 全球治療藥物臨床實驗, 前幾名企業 各階段
  • 敗血性休克 全球治療藥物臨床實驗, 臨床實驗 - 潛力治療藥物
  • 敗血性休克 全球治療藥物臨床實驗市場, 臨床實驗 - AstraZeneca PLC
  • 敗血性休克 全球治療藥物臨床實驗市場, 臨床實驗 - Hospital Distrital Dr Fernandes Tavora
  • 敗血性休克 全球治療藥物臨床實驗市場, 臨床實驗 - Fraser Health Corporate Office
  • 敗血性休克 全球治療藥物臨床實驗市場, 臨床實驗 - Athlomics Pty Ltd
  • 敗血性休克 全球治療藥物臨床實驗市場, 臨床實驗 - Laboratoire francais de Fractionnement et de Biotechnologies
  • 敗血性休克 全球治療藥物臨床實驗市場, 臨床實驗 - Aventis Behring GmbH
  • 敗血性休克 全球治療藥物臨床實驗市場, 臨床實驗 - Ferring Pharmaceuticals, Inc.
  • 敗血性休克 全球治療藥物臨床實驗市場, 臨床實驗 - Spectral Diagnostics Inc.
  • 敗血性休克 全球治療藥物臨床實驗市場, 臨床實驗 - Atox Bio Inc.
  • 敗血性休克 全球治療藥物臨床實驗市場, 臨床實驗 - Eisai公司
  • 敗血性休克 全球治療藥物臨床實驗市場, 臨床實驗 - Green Cross Corporation
  • 敗血性休克 全球治療藥物臨床實驗市場, 臨床實驗 - Eli Lilly and Company
  • 敗血性休克 全球治療藥物臨床實驗市場, 臨床實驗 - Sapienza University of Rome
  • 敗血性休克 全球治療藥物臨床實驗市場, 臨床實驗 - Beth Israel Deaconess Medical Center
  • 敗血性休克 全球治療藥物臨床實驗市場, 臨床實驗 - Charite University
  • 敗血性休克 全球治療藥物臨床實驗市場, 臨床實驗 - The University of Texas Health Science Center at Houston
  • 敗血性休克 全球治療藥物臨床實驗市場, 臨床實驗 - The Medical Center Leeuwarden
  • 敗血性休克 全球治療藥物臨床實驗市場, 臨床實驗 - Herlev Hospital
  • 敗血性休克 全球治療藥物臨床實驗市場, 臨床實驗 - Carolinas Healthcare System
  • 敗血性休克 全球治療藥物臨床實驗市場, 臨床實驗 - Mahidol University
  • 敗血性休克 全球治療藥物臨床實驗市場, 臨床實驗 - Hospital Clinic de Barcelona
  • 敗血性休克 全球治療藥物臨床實驗市場, 臨床實驗 - University of Sao Paulo
  • 敗血性休克 全球治療藥物臨床實驗市場, 臨床實驗 - 倫敦 Health Sciences Centre
  • 敗血性休克 全球治療藥物臨床實驗市場, 臨床實驗 - Research & Diagnostic Antibodies
  • 敗血性休克 全球治療藥物臨床實驗市場, 臨床實驗 - Southeast University
  • 敗血性休克 全球治療藥物臨床實驗市場, 臨床實驗 - University Hospital, Grenoble
  • 敗血性休克 全球治療藥物臨床實驗市場, 臨床實驗 - Washington University School of Medicine
  • 敗血性休克 全球治療藥物臨床實驗市場, 臨床實驗 - Assistance Publique - Hopitaux de Paris
  • 敗血性休克 全球治療藥物臨床實驗市場, 臨床實驗 - Austin Health
  • 敗血性休克 全球治療藥物臨床實驗市場, 臨床實驗 - University of Copenhagen
  • 敗血性休克 全球治療藥物臨床實驗市場, 臨床實驗 - National Center for Genome Resources
  • 敗血性休克 全球治療藥物臨床實驗市場, 臨床實驗 - Rush University Medical Center

圖表一覽

  • 敗血性休克 全球治療藥物市場, 臨床實驗 各地區 (%)
  • 敗血性休克 全球治療藥物市場, 臨床實驗 各國排名
  • 敗血性休克 全球治療藥物市場, 進行中的臨床實驗 各國排名
  • 敗血性休克 治療藥物的臨床實驗, 亞太地區, 前五國 (%)
  • 敗血性休克 治療藥物的臨床實驗, 歐洲, 前五國 (%)
  • 敗血性休克 治療藥物的臨床實驗, 北美, 前幾名國家 (%)
  • 敗血性休克 治療藥物的臨床實驗, 中南美, 前幾名國家 (%)
  • 敗血性休克 治療藥物的臨床實驗, 金磚四國 各國 (%)
  • 敗血性休克 治療藥物的臨床實驗, G7 各國 (%)
  • 敗血性休克 治療藥物市場, G7 各國, 臨床實驗 各臨床實驗狀態
  • 敗血性休克 治療藥物的臨床實驗, E7 各國 (%)
  • 敗血性休克 治療藥物市場, E7 各國, 臨床實驗 各臨床實驗狀態
  • 敗血性休克 全球治療藥物市場, 臨床實驗 各階段 (%)
  • 敗血性休克 全球治療藥物市場, 進行中的臨床實驗 各階段
  • 敗血性休克 全球治療藥物市場, 臨床實驗 各臨床實驗狀態
  • 敗血性休克 全球治療藥物臨床實驗, 平均登錄對象人數趨勢
  • 敗血性休克 全球治療藥物臨床實驗, 主要的贊助商
  • 敗血性休克 全球治療藥物臨床實驗, 前幾名企業 各階段
  • 敗血性休克 全球治療藥物臨床實驗, 臨床實驗 - 潛力治療藥物
  • GlobalData 調查方法

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄

Abstract

Septic Shock Global Clinical Trials Review, H2, 2012

Summary

GlobalData's clinical trial report, "Septic Shock Global Clinical Trials Review, H2, 2012" provides data on the Septic Shock clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Septic Shock. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Septic Shock. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Keywords

Septic Shock Clinical Trials, Trial Designs, Subjects Recruited, Unaccomplished Trials of Septic Shock, Pfizer, AstraZeneca, Novartis, GlaxoSmithKline, Sanofi, Eli Lilly and Company, Johnson & Johnson, Merck & Co., Inc, Bristol-Myers Squibb Company, Abbott Laboratories, Hoffmann-La Roche Ltd., Celgene Corporation, Daiichi Sankyo Company, Ltd., Bayer AG, Eisai Inc., GE Healthcare, Biogen Idec Inc., Copharos Inc., Wyeth Pharmaceuticals Inc., National Cancer Center, The University of Texas, M.D. Andersons, Vanderbilt Medical Center, Memorial Sloan Kettering Cancer Center, Cancer Research UK, North Central Cancer Group, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Fred Hutchinson Cancer Research Center, European Organization for Research and Treatment of Cancer, Dana-Farber Cancer Institute, The Cancer and Leukemia Group B, Columbia University, UCLA's Jonsson Comprehensive Cancer Center, Case Comprehensive Cancer Center, Mayo Clinic, Duke University, Ohio State University, National Cancer Center, University of Pennsylvania.

TOC

Table of Contents

Table of Contents 2

  • List of Tables 5
  • List of Figures 6
  • Introduction 7
  • Septic Shock 7
  • Report Guidance 7
  • Clinical Trials by Region 8
  • Clinical Trials by Country 9
  • Top Five Countries Contributing to Clinical Trials in Asia-Pacific 11
  • Top Five Countries Contributing to Clinical Trials in Europe 12
  • Top Countries Contributing to Clinical Trials in North America 13
  • Top Countries Contributing to Clinical Trials in Middle East and Africa 14
  • Top Countries Contributing to Clinical Trials in Central and South America 15
  • Clinical Trials by BRIC Nations 16
  • Clinical Trials by G7 Nations 17
  • Clinical Trials in G7 Nations by Trial Status 18
  • Clinical Trials by E7 Nations 19
  • Clinical Trials in E7 Nations by Trial Status 20
  • Clinical Trials by Phase 21
  • In Progress Trials by Phase 22
  • Clinical Trials by Trial Status 23
  • Unaccomplished Trials of Septic Shock 24
  • Subjects Recruited Over a Period of Time 26
  • Prominent Sponsors 27
  • Top Companies Participating in Septic Shock Therapeutics Clinical Trials 29
  • Prominent Drug Comparison 31
  • Clinical Trial Profiles 32
  • Clinical Trial Overview of Top Companies 32
  • Ferring Pharmaceuticals, Inc. 32
  • Clinical Trial Overview of Ferring Pharmaceuticals, Inc. 32
  • AstraZeneca PLC 33
  • Clinical Trial Overview of AstraZeneca PLC 33
  • Gambro KK 34
  • Clinical Trial Overview of Gambro KK 34
  • Kompetenznetz Sepsis 35
  • Clinical Trial Overview of Kompetenznetz Sepsis 35
  • Fraser Health Corporate Office 36
  • Clinical Trial Overview of Fraser Health Corporate Office 36
  • Thrombologic ApS 37
  • Clinical Trial Overview of Thrombologic ApS 37
  • Athlomics Pty Ltd 38
  • Clinical Trial Overview of Athlomics Pty Ltd 38
  • Laboratoire francais de Fractionnement et de Biotechnologies 39
  • Clinical Trial Overview of Laboratoire francais de Fractionnement et de Biotechnologies 39
  • Aventis Behring GmbH 40
  • Clinical Trial Overview of Aventis Behring GmbH 40
  • Atox Bio Inc. 41
  • Clinical Trial Overview of Atox Bio Inc. 41
  • Eisai Inc. 42
  • Clinical Trial Overview of Eisai Inc. 42
  • Green Cross Corporation 43
  • Clinical Trial Overview of Green Cross Corporation 43
  • Children's Healthcare of Atlanta Inc. 44
  • Clinical Trial Overview of Children's Healthcare of Atlanta Inc. 44
  • Research & Diagnostic Antibodies 45
  • Clinical Trial Overview of Research & Diagnostic Antibodies 45
  • Sirius Genomics Inc. 46
  • Clinical Trial Overview of Sirius Genomics Inc. 46
  • Eli Lilly and Company 47
  • Clinical Trial Overview of Eli Lilly and Company 47
  • Clinical Trial Overview of Top Universities / Institutes / Hospitals 48
  • Sapienza University of Rome 48
  • Clinical Trial Overview of Sapienza University of Rome 48
  • Beth Israel Deaconess Medical Center 49
  • Clinical Trial Overview of Beth Israel Deaconess Medical Center 49
  • Assistance Publique - Hopitaux de Paris 50
  • Clinical Trial Overview of Assistance Publique - Hopitaux de Paris 50
  • Charite- Universitatsmedizin Berlin 51
  • Clinical Trial Overview of Charite- Universitatsmedizin Berlin 51
  • The University of Texas Health Science Center at Houston 52
  • Clinical Trial Overview of The University of Texas Health Science Center at Houston 52
  • The Medical Center Leeuwarden 53
  • Clinical Trial Overview of The Medical Center Leeuwarden 53
  • University Hospital Inselspital, Berne 54
  • Clinical Trial Overview of University Hospital Inselspital, Berne 54
  • Herlev Hospital 55
  • Clinical Trial Overview of Herlev Hospital 55
  • Carolinas Healthcare System 56
  • Clinical Trial Overview of Carolinas Healthcare System 56
  • University of Sao Paulo 57
  • Clinical Trial Overview of University of Sao Paulo 57
  • Seattle Children's Hospital 58
  • Clinical Trial Overview of Seattle Children's Hospital 58
  • University of Versailles 59
  • Clinical Trial Overview of University of Versailles 59
  • Mahidol University 60
  • Clinical Trial Overview of Mahidol University 60
  • Montpellier University Hospital 61
  • Clinical Trial Overview of Montpellier University Hospital 61
  • London Health Sciences Centre 62
  • Clinical Trial Overview of London Health Sciences Centre 62
  • Samsung Medical Center 63
  • Clinical Trial Overview of Samsung Medical Center 63
  • University of Colorado 64
  • Clinical Trial Overview of University of Colorado 64
  • University of Copenhagen 65
  • Clinical Trial Overview of University of Copenhagen 65
  • National Taiwan University Hospital 66
  • Clinical Trial Overview of National Taiwan University Hospital 66
  • Rush University Medical Center 67
  • Clinical Trial Overview of Rush University Medical Center 67
  • Five Key Clinical Profiles 68

Appendix 84

  • Abbreviations 84
  • Definitions 84
  • Research Methodology 85
  • Secondary Research 85
  • About GlobalData 86
  • Contact Us 86
  • Disclaimer 86
  • Source 87

List of Tables

List of Tables

  • Septic Shock Therapeutics Market, Global, Clinical Trials by Zone, 2012* 8
  • Septic Shock Therapeutics Market, Global, Clinical Trials by Top Countries, 2012* 9
  • Septic Shock Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012* 10
  • Septic Shock Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2012* 11
  • Septic Shock Therapeutics Clinical Trials, Europe, Top Five Countries, 2012* 12
  • Septic Shock Therapeutics Clinical Trials, North America, Top Countries, 2012* 13
  • Septic Shock Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2012* 14
  • Septic Shock Therapeutics Clinical Trials, Central and South America, Top Countries, 2012* 15
  • Septic Shock Therapeutics Clinical Trials, BRIC Countries, 2012* 16
  • Septic Shock Therapeutics Clinical Trials, G7 Countries, 2012* 17
  • Septic Shock Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012* 18
  • Septic Shock Therapeutics Clinical Trials, E7 Countries, 2012* 19
  • Septic Shock Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012* 20
  • Septic Shock Therapeutics Market, Global, Clinical Trials by Phase, 2012* 21
  • Septic Shock Therapeutics Market, Global, Clinical Trials In Progress by Phase 2012* 22
  • Septic Shock Therapeutics Market, Global, Clinical Trials by Trial Status, 2012* 23
  • Septic Shock Therapeutics Market, Global, Suspended Clinical Trials, 2012* 24
  • Septic Shock Therapeutics Market, Global, Terminated Clinical Trials, 2012* 25
  • Septic Shock Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2006-2011 26
  • Septic Shock Therapeutics Clinical Trials, Global, Key Sponsors, 2012* 28
  • Septic Shock Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012* 30
  • Septic Shock Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012* 31
  • Septic Shock Therapeutics Clinical Trials Market, Global, Clinical Trials by Ferring Pharmaceuticals, Inc., 2012* 32
  • Septic Shock Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2012* 33
  • Septic Shock Therapeutics Clinical Trials Market, Global, Clinical Trials by Gambro KK, 2012* 34
  • Septic Shock Therapeutics Clinical Trials Market, Global, Clinical Trials by Kompetenznetz Sepsis, 2012* 35
  • Septic Shock Therapeutics Clinical Trials Market, Global, Clinical Trials by Fraser Health Corporate Office, 2012* 36
  • Septic Shock Therapeutics Clinical Trials Market, Global, Clinical Trials by Thrombologic ApS, 2012* 37
  • Septic Shock Therapeutics Clinical Trials Market, Global, Clinical Trials by Athlomics Pty Ltd, 2012* 38
  • Septic Shock Therapeutics Clinical Trials Market, Global, Clinical Trials by Laboratoire francais de Fractionnement et de Biotechnologies, 2012* 39
  • Septic Shock Therapeutics Clinical Trials Market, Global, Clinical Trials by Aventis Behring GmbH, 2012* 40
  • Septic Shock Therapeutics Clinical Trials Market, Global, Clinical Trials by Atox Bio Inc., 2012* 41
  • Septic Shock Therapeutics Clinical Trials Market, Global, Clinical Trials by Eisai Inc., 2012* 42
  • Septic Shock Therapeutics Clinical Trials Market, Global, Clinical Trials by Green Cross Corporation, 2012* 43
  • Septic Shock Therapeutics Clinical Trials Market, Global, Clinical Trials by Children's Healthcare of Atlanta Inc., 2012* 44
  • Septic Shock Therapeutics Clinical Trials Market, Global, Clinical Trials by Research & Diagnostic Antibodies, 2012* 45
  • Septic Shock Therapeutics Clinical Trials Market, Global, Clinical Trials by Sirius Genomics Inc., 2012* 46
  • Septic Shock Therapeutics Clinical Trials Market, Global, Clinical Trials by Eli Lilly and Company, 2012* 47
  • Septic Shock Therapeutics Clinical Trials Market, Global, Clinical Trials by Sapienza University of Rome, 2012* 48
  • Septic Shock Therapeutics Clinical Trials Market, Global, Clinical Trials by Beth Israel Deaconess Medical Center, 2012* 49
  • Septic Shock Therapeutics Clinical Trials Market, Global, Clinical Trials by Assistance Publique - Hopitaux de Paris, 2012* 50
  • Septic Shock Therapeutics Clinical Trials Market, Global, Clinical Trials by Charite- Universitatsmedizin Berlin, 2012* 51
  • Septic Shock Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Texas Health Science Center at Houston, 2012* 52
  • Septic Shock Therapeutics Clinical Trials Market, Global, Clinical Trials by The Medical Center Leeuwarden, 2012* 53
  • Septic Shock Therapeutics Clinical Trials Market, Global, Clinical Trials by University Hospital Inselspital, Berne, 2012* 54
  • Septic Shock Therapeutics Clinical Trials Market, Global, Clinical Trials by Herlev Hospital, 2012* 55
  • Septic Shock Therapeutics Clinical Trials Market, Global, Clinical Trials by Carolinas Healthcare System, 2012* 56
  • Septic Shock Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Sao Paulo, 2012* 57
  • Septic Shock Therapeutics Clinical Trials Market, Global, Clinical Trials by Seattle Children's Hospital, 2012* 58
  • Septic Shock Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Versailles, 2012* 59
  • Septic Shock Therapeutics Clinical Trials Market, Global, Clinical Trials by Mahidol University, 2012* 60
  • Septic Shock Therapeutics Clinical Trials Market, Global, Clinical Trials by Montpellier University Hospital, 2012* 61
  • Septic Shock Therapeutics Clinical Trials Market, Global, Clinical Trials by London Health Sciences Centre, 2012* 62
  • Septic Shock Therapeutics Clinical Trials Market, Global, Clinical Trials by Samsung Medical Center, 2012* 63
  • Septic Shock Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Colorado, 2012* 64
  • Septic Shock Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Copenhagen, 2012* 65
  • Septic Shock Therapeutics Clinical Trials Market, Global, Clinical Trials by National Taiwan University Hospital, 2012* 66
  • Septic Shock Therapeutics Clinical Trials Market, Global, Clinical Trials by Rush University Medical Center, 2012* 67

List of Figures

List of Figures

  • Septic Shock Therapeutics Market, Global, Clinical Trials by Zone (%), 2012* 8
  • Septic Shock Therapeutics Market, Global, Clinical Trials by Top Countries, 2012* 9
  • Septic Shock Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012* 10
  • Septic Shock Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2012* 11
  • Septic Shock Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2012* 12
  • Septic Shock Therapeutics Clinical Trials, North America, Top Countries (%), 2012* 13
  • Septic Shock Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2012* 15
  • Septic Shock Therapeutics Clinical Trials, BRIC Countries (%), 2012* 16
  • Septic Shock Therapeutics Clinical Trials, G7 Countries (%), 2012* 17
  • Septic Shock Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012* 18
  • Septic Shock Therapeutics Clinical Trials, E7 Countries (%), 2012* 19
  • Septic Shock Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012* 20
  • Septic Shock Therapeutics Market, Global, Clinical Trials by Phase (%), 2012* 21
  • Septic Shock Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2012* 22
  • Septic Shock Therapeutics Market, Global, Clinical Trials by Trial Status, 2012* 23
  • Septic Shock Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2006-2011 26
  • Septic Shock Therapeutics Clinical Trials, Global, Key Sponsors, 2012* 27
  • Septic Shock Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012* 29
  • Septic Shock Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012* 31
  • GlobalData Methodology 85

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

敗血性休克:全球臨床實驗檢討是由出版商GlobalData在2012年08月15日所出版的。這份市場調查報告書包含Pages: 87 價格從美金2500起跳。

Back to Top
;